Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPANK Block vs ACB for Post-TKA Pain
NCT04290442Phase 4Withdrawn
- Start
- Jan 2021
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Pain score using Numerical rating Scale (NRS) with ambulation at 24 hours after total knee arthroplasty. Planned start Jan 2021; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04290442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04290442.